tirzepatide through lilly FDA says the weight-loss drug shortage is over FDA approves tirzepatide, Eli Lilly's

Safety considerations require clinical vigilance

This bridge program will now allow Medicare beneficiaries access to GLP-1 medications for weight loss through a monthly subscription model, which raises important questions about who pays, how much it will cost, and whether the program can be sustained long term, Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek

Semaglutide users navigating this landscape need to separate genuine quality indicators from marketing noise

When it comes to weight management and GLP-1 coverage: Some MA plans may offer fitness benefits like gym memberships (SilverSneakers, Renew Active) that support weight management goals Formulary differences matter: Each MA plan with drug coverage has its own formulary, so GLP-1 coverage for approved conditions (diabetes, cardiovascular risk) can vary significantly from plan to plan GLP-1 Bridge access: MA plans that include prescription drug coverage (MA-PD plans) are included in the GLP-1 Bridge program, so members of those plans can participate starting July 2026 Supplemental benefits: Some MA plans offer nutritional counseling, meal delivery, or wellness programs that can complement weight management efforts If weight management is a priority for you, it's worth comparing how different plans handle these benefits

Why is Kennedy so interested in peptides

Across these studies, semaglutide 2.4 mg (the dose used for weight management) showed consistent and significant weight-loss results